Content about Biology

January 14, 2014

An educational program partially conceived by a group focused on lupus research is expected to receive $2 million through a congressional appropriations bill.

NEW YORK — An educational program partially conceived by a group focused on lupus research is expected to receive $2 million through a congressional appropriations bill.

January 14, 2014

LifeScan introduced the new OneTouch VerioSync Meter, which uses Bluetooth technology to wirelessly send blood sugar test results to devices using the OneTouch Reveal mobile app.

MILPITAS, Calif. — LifeScan on Monday introduced the new OneTouch VerioSync Meter, which uses Bluetooth technology to wirelessly send blood sugar test results to devices using the OneTouch Reveal mobile app.

January 13, 2014

Finnish beauty brand Lumene is kicking off 2014 with a bang, the company said, as it revamps packaging, broadens its portfolio with new formulas and prepares to expand into Rite Aid stores.

NEW YORK — Finnish beauty brand Lumene is kicking off 2014 with a bang, the company said, as it revamps packaging, broadens its portfolio with new formulas and prepares to expand into Rite Aid stores.

To highlight the skin care benefits of vitamin C, Lumene’s Vitamin C+ is now known as Bright Now Vitamin C+. The range, which is targeted to women ages 25 years and older, leverages the power of arctic cloudberry nectar and seed oil and vitamin C to brighten and protect the skin while preventing the first signs of aging.

January 13, 2014

Real Health Labs recently launched Prostate Complete Once Per Day, a pharmaceutical-grade supplement combination, the company stated.

SAN DIEGO — Real Health Labs recently launched Prostate Complete Once Per Day, a pharmaceutical-grade supplement combination, the company stated. 

In addition to zinc, selenium and vitamin E, Prostate Complete Once Per Day is formulated with a standardized saw palmetto extract, lycopene, a standardized curcumin extract, resveratrol and a pomegranate concentrate. 

January 10, 2014

Maloof Ventures announced on Friday the launch of Never Hungover at GNC.

LOS ANGELES — Maloof Ventures announced on Friday the launch of Never Hungover at GNC. Never Hungover is a dietary supplement that is comprised of a natural vitamin blend, antioxidants, amino acids, nutrients and minerals packaged as a 2-oz. serving. 

The hangover shot is designed to take up to an hour before or while consuming alcohol, and experiences optimal results when taking one bottle per four drinks. 

January 9, 2014

Intensive Recovery Beauty Oil by Lumene, which is part of the brand’s Complete Rewind collection, aims to battle the appearance of wrinkles and uneven skin tone with essential fatty acids (e.g., omega-3, 6, 7 and 9) and vitamins from antioxidant-rich Arctic sea buckthorn.

ESPOO, Finland — Intensive Recovery Beauty Oil by Lumene, which is part of the brand’s Complete Rewind collection, aims to battle the appearance of wrinkles and uneven skin tone with essential fatty acids (e.g., omega-3, 6, 7 and 9) and vitamins from antioxidant-rich Arctic sea buckthorn.

January 9, 2014

Sales of vitamins and minerals represent a $6.5 billion book of business that’s growing at a 5.2% clip across total U.S. multi-outlets for the 52 weeks ended Nov. 3, 2013, according to IRI.

Sales of vitamins and minerals represent a $6.5 billion book of business that’s growing at a 5.2% clip across total U.S. multi-outlets for the 52 weeks ended Nov. 3, 2013, according to IRI.

(For the full category review, including sales data, click here.)

January 9, 2014

Probiotics is another large-scale source of growth for the vitamins, minerals and supplements category, having realized a 33% rate of growth, or an increase in sales of $121 million in the last year, noted Doug Jones, Pharmavite spokesman.

Probiotics is another large-scale source of growth for the vitamins, minerals and supplements category, having realized a 33% rate of growth, or an increase in sales of $121 million in the last year, noted Doug Jones, Pharmavite spokesman.

(For the full category review, including sales data, click here.)

January 8, 2014

Japanese drug maker Daiichi Sankyo is seeking Food and Drug Administration approval for a once-daily tablet to reduce the risk of stroke in patients with atrial fibrillation and treatment of other conditions.

PARSIPPANY, N.J. — Japanese drug maker Daiichi Sankyo is seeking Food and Drug Administration approval for a once-daily tablet to reduce the risk of stroke in patients with atrial fibrillation and treatment of other conditions.

Daiichi Sankyo announced the submission of a new drug application for Savaysa (edoxaban). The company also is hoping to get the FDA's approval for the pill as a treatment for deep vein thrombosis and pulmonary embolism, as well as preventing the recurrence of symptomatic venous thromboembolism.

January 7, 2014

The Federal Trade Commission announced a law enforcement initiative stopping national marketers that used deceptive advertising claims to peddle fad weight-loss products, from food additives and skin cream to dietary supplements.

WASHINGTON — The Federal Trade Commission on Tuesday announced a law enforcement initiative stopping national marketers that used deceptive advertising claims to peddle fad weight-loss products, from food additives and skin cream to dietary supplements.

January 3, 2014

Nipro Diagnostics announced it is initiating a voluntary recall and replacement of a limited number of TRUEbalance and TRUEtrack Blood Glucose Meters distributed both in the United States and outside the United States.

FORT LAUDERDALE, Fla. — Nipro Diagnostics on Thursday announced it is initiating a voluntary recall and replacement of a limited number of TRUEbalance and TRUEtrack Blood Glucose Meters distributed both in the United States and outside the United States.

January 2, 2014

Among patients with mild to moderate Alzheimer disease, a daily dosage of 2,000 IUs of vitamin E, compared to placebo, was effective in slowing functional decline and in reducing caregiver time in assisting patients, according to a study that appeared in the Jan. 1 issue of JAMA.

CHICAGO — Among patients with mild to moderate Alzheimer disease, a daily dosage of 2,000 IUs of vitamin E, compared to placebo, was effective in slowing functional decline and in reducing caregiver time in assisting patients, according to a study that appeared in the Jan. 1 issue of the Journal of the American Medical Association.

December 26, 2013

Core Science Medica has targeted consumers in need of a gluten-free lifestyle with its launch of Gluten Cutter, a dietary supplement to help gluten-sensitive consumers occasionally enjoy their favorite foods again.

WEST PALM BEACH, Fla. — Core Science Medica has targeted consumers in need of a gluten-free lifestyle with its launch of Gluten Cutter, a dietary supplement to help gluten-sensitive consumers occasionally enjoy their favorite foods again. The supplement contains GCX50, a proprietary blend of enzymes, along with licorice, peppermint and ginger. The complex is designed to target and break down gluten, support intestinal health during gluten exposure and aid digestion.

December 26, 2013

Probiotics have continued to rake in sales this fall, and it’s a product category that still has plenty of growth potential.

Probiotics have continued to rake in sales this fall, and it’s a product category that still has plenty of growth potential. According to a survey by Procter & Gamble, 53% of women still don’t know what probiotics are, but 74% are interested in how their digestive system works.

(For the full category review, including sales data, click here.)

December 23, 2013

Two experimental drugs under development by Biogen Idec are effective in reducing bleeding episodes in patients with two forms of hemophilia when administered as a preventive treatment, while also reducing the need for frequent injections, according to late-stage clinical trial data.

NEW YORK — Two experimental drugs under development by Biogen Idec are effective in reducing bleeding episodes in patients with two forms of hemophilia when administered as a preventive treatment, while also reducing the need for frequent injections, according to late-stage clinical trial data.

December 23, 2013

In two separate clinical trials, researchers at Albert Einstein College of Medicine of Yeshiva University have found that periodic meetings with a lactation consultant encourages women traditionally resistant to breast-feeding to do so, at least for a few months, or long enough for mother and child to gain health benefits.

NEW YORK — In two separate clinical trials, researchers at Albert Einstein College of Medicine of Yeshiva University have found that periodic meetings with a lactation consultant encourages women traditionally resistant to breast-feeding to do so, at least for a few months, or long enough for mother and child to gain health benefits. The results of the trials were published online last week in American Journal of Public Health.

December 18, 2013

Respiratory Syncytial Virus appears to cause milder illness than influenza in adults age 50 or older, researchers at Marshfield Clinic Research Foundation announced,

MARSHFIELD, Wis. — Respiratory Syncytial Virus appears to cause milder illness than influenza in adults age 50 or older, researchers at Marshfield Clinic Research Foundation announced Wednesday.

The study, published online in Clinical Infectious Diseases, also shows RSV is a common cause of respiratory illness in older adults and that the chance of infection increases with age.

December 17, 2013

Consumer advocates worry that misconceptions and fears about the safety and effectiveness of flu vaccines are hindering efforts to get children vaccinated, according to a new survey.

WASHINGTON — Consumer advocates worry that misconceptions and fears about the safety and effectiveness of flu vaccines are hindering efforts to get children vaccinated, according to a new survey.

December 16, 2013

The Food and Drug Administration may require makers of antibacterial soaps to perform clinical trials to show their products are better at preventing infections and disease than ordinary soaps.

SILVER SPRING, Md. — The Food and Drug Administration may require makers of antibacterial soaps to perform clinical trials to show their products are better at preventing infections and disease than ordinary soaps, part of a larger effort by the agency to ensure the safety and efficacy of antibacterial products and slow down the rise of antibiotic-resistant bacteria.

December 16, 2013

In support of the more than 1.1 million people living with HIV in the United States, Walgreens on Monday announced its collaboration with the Centers for Disease Control and Prevention to develop and evaluate a model of HIV patient-centered care through a national project aimed at advancing clinical integration and medication therapy management.

DEERFIELD, Ill. — In support of the more than 1.1 million people living with HIV in the United States, Walgreens on Monday announced its collaboration with the Centers for Disease Control and Prevention to develop and evaluate a model of HIV patient-centered care through a national project aimed at advancing clinical integration and medication therapy management. The program is another way Walgreens is extending its commitment to improve HIV prevention and treatment outcomes.

December 13, 2013

A recent study commissioned by Intel revealed that patients are ready to embrace personalized care, all the way down to medications for their specific genetic makeup, and they want the freedom to get health care wherever and whenever it’s convenient for them.

Why is this important? Personalization — whether it is customized coupons and marketing or prescription medications — is here and will be critical in 2014. Consumers want more, and in the face of rising healthcare costs and a strained health care system, their healthcare is no exception.

A recent study commissioned by Intel revealed that patients are ready to embrace personalized care, all the way down to medications for their specific genetic makeup, and they want the freedom to get health care wherever and whenever it’s convenient for them.

December 13, 2013

MarketsandMarkets on Friday projected the global probiotics market would reach $23.9 billion by 2017.

DALLAS — MarketsandMarkets on Friday projected the global probiotics market would reach $23.9 billion by 2017. 

"[The] probiotics market has been one of the prime beneficiaries of the recent fad over functional foods," MarketsandMarkets reported. "Rising levels of health consciousness and aging baby boomer population are a few of the drivers helping in the growth of the market. 

December 12, 2013

Diabetes organizations in several cities are getting a boost in funding from a Danish drug maker that specializes in developing treatments for the disease.

NEW YORK — Diabetes organizations in several cities are getting a boost in funding from a Danish drug maker that specializes in developing treatments for the disease.

Novo Nordisk said it would provide funding to groups in Seattle; Portland, Ore.; and Rochester, Minn., as part of the Novo Nordisk Community Care initiative. The initiative provides funding to nonprofits that support educational programs for people with Type 2 diabetes.

December 11, 2013

The Food and Drug Administration is planning to limit the use of antimicrobials in food animals in an effort to stem the rise of antibiotic-resistant bacteria, the agency said Wednesday.

SILVER SPRING, Md. – The Food and Drug Administration is planning to limit the use of antimicrobials in food animals in an effort to stem the rise of antibiotic-resistant bacteria, the agency said Wednesday.

December 10, 2013

Personalized medicine is on the horizon, and patients are not only awaiting it optimistically, but they also are willing to share a bit of personal information when it comes, according to a new study released Monday commissioned by Intel.

SANTA CLARA, Calif. — Personalized medicine is on the horizon, and patients are not only awaiting it optimistically, but they also are willing to share a bit of personal information when it comes, according to a new study released Monday commissioned by Intel.